内部人交易雷达美国 · SEC FORM 4
Lycia Therapeutics, Inc.
LYCA · — · CIK 0001806540 · Healthcare · Biotechnology
内部人信号
64.7 / 100
1 位买方 · 12 条买入交易行 · $38.5M 买入总额
为什么有这个信号？
买方广度较低
买入规模较强
角色中等
近期性较强
确信度较强
评分构成
每条进度条是这一部分在总分里的分数，五项相加就是总分。
买入人数+7.0 / 35
买入金额+24.2 / 25
Buyers' roles+14.0 / 20
多近+9.5 / 10
买入与卖出+10.0 / 10
哪些因素限制了当前分数？
- ⚠ 买入人数不多 · 1 位内部人，不到 4 位
- ⚠ Buyers' roles add little · most senior buyer: TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
- ✓ 买入很近 · 最近一次在 2026-11-02
日均成交量在页面其他位置作为市场背景列出，不计入评分。
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道按交易日绘制；菱形标记较晚的公开披露日，在此之前市场并不知道该交易。卖出仅作背景。
MayJunJulAugSepOctNov
Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P.TenPercentOwner
●◇○◇●◇●●◇●◇●●◇
Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLCTenPercentOwner
○◇
● 买入▼ 卖出○ 其他◇ 公开披露
—
买方广度与集中度
合资格买方1
买入集中度100%最大买方： Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. · $38.5M
聚集买入 · 15天1 insider峰值活动： 2026-10-23–2026-11-02
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
64.7 / 100
最新留档分数
↑ +0.3 pts相对上一个留档快照
- 65.1
- 64.9
- 64.7
- 64.4
- 64.7
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
12买入
0卖出
3其他 Form 4 交易行
4SEC 申报 · 365天
买入12 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他3 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not detected in parsed evidence
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- —
- 3M
- —
- 6M
- —
- 12M
- —
波动率与流动性
- 波动率
- —
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-11-06 · 价格来源：OpenBB/yfinance · Status: PASS
股利
近五年没有发放现金股利。
数据来自 Yahoo Finance：按除息日统计的现金股利、最新收盘价、派息率（股利 ÷ 近 12 个月每股盈利）和已公布的日期；包括特别股利，不包括股票股利和拆股。不进入任何评分。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-10-15 · 获取日期 2026-11-03 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| 交易日期 | 披露日期 | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-04 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 8,305 | USD 26.95 | USD 223,820 | SEC 申报 ↗ |
| 2026-10-30 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 9,004 | USD 26.28 | USD 236,653 | SEC 申报 ↗ |
| 2026-10-29 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 1,000 | USD 26.33 | USD 26,330 | SEC 申报 ↗ |
| 2026-10-28 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 15,000 | USD 25.45 | USD 381,728 | SEC 申报 ↗ |
| 2026-10-27 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 39,796 | USD 26.62 | USD 1,059,396 | SEC 申报 ↗ |
| 2026-10-26 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 1,952,705 | USD 18.04 | USD 35,222,791 | SEC 申报 ↗ |
| 2026-10-23 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 52,939 | USD 25.91 | USD 1,371,676 | SEC 申报 ↗ |
Form 4 申报证据
15 transaction lines in the latest 365-day window; 15 in local history.
| 交易日期 | 披露日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-04 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 8,305 | USD 26.95 | USD 223,820 | SEC 申报 ↗ |
| 2026-10-30 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 9,004 | USD 26.28 | USD 236,653 | SEC 申报 ↗ |
| 2026-10-29 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 1,000 | USD 26.33 | USD 26,330 | SEC 申报 ↗ |
展开近期 Form 4 证据 (9 grouped rows)
| 交易日期 | 披露日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-04 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 8,305 | USD 26.95 | USD 223,820 | SEC 申报 ↗ |
| 2026-10-30 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 9,004 | USD 26.28 | USD 236,653 | SEC 申报 ↗ |
| 2026-10-29 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 1,000 | USD 26.33 | USD 26,330 | SEC 申报 ↗ |
| 2026-10-28 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 15,000 | USD 25.45 | USD 381,728 | SEC 申报 ↗ |
| 2026-10-27 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 39,796 | USD 26.62 | USD 1,059,396 | SEC 申报 ↗ |
| 2026-10-26 | 2026-10-28 | Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC | C (C) | Common Stock | 7,025,307 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-26 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 1,952,705 | USD 18.04 | USD 35,222,791 | SEC 申报 ↗ |
| 2026-10-26 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | C (C) | Common Stock | 4,779,793 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-23 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | 买入 (P) | Common Stock | 52,939 | USD 25.91 | USD 1,371,676 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-11-05 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | REVIEW MAPPING_REVIEW · mapping-review-required |
| 股票代码 | LYCA |
| CIK | 0001806540 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 15 transaction lines from 2026-10-23 to 2026-11-02 12 P purchase lines · 0 S sale lines · 3 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-11-05. Mapping status is an audit field and does not erase SEC filing evidence.